Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis

Fingolimod is an oral immunomodulatory drug used in the treatment of multiple sclerosis (MS) that may change lipid metabolism. Peroxisome proliferator-activated receptors (PPAR) are transcription factors that regulate lipoprotein metabolism and immune functions and have been implicated in the pathop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferret-Sena, Véronique, Capela, Carlos, Macedo, Ana, Salgado, António Vasco, Derudas, Bruno, Staels, Bart, Sena, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797671/
https://www.ncbi.nlm.nih.gov/pubmed/36590913
http://dx.doi.org/10.3389/fnmol.2022.1077381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797671/
https://www.ncbi.nlm.nih.gov/pubmed/36590913
http://dx.doi.org/10.3389/fnmol.2022.1077381

Ejemplares similares